Warfarin dose requirement during induction correlates with CYP2C9 genetic polymorphism.

被引：0
|
作者：
Muszkat, M [1 ]
Elami, A [1 ]
Krasilnikov, I [1 ]
Caraco, Y [1 ]
机构：
[1] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [21] Frequency of Common CYP2C9 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population
    Qayyum, Aisha
    Najmi, Muzammil Hasan
    Mansoor, Qaisar
    Farooqi, Zia-ur-Rehman
    Naveed, Abdul Khaliq
    Hanif, Andleeb
    Kazmi, Syed Ali Raza
    Ismail, Muhammad
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (07) : 800 - 806
  • [22] Low dose requirement for warfarin treatment in a patient with CYP2C9*3/*13 genotype
    Kwon, Min-Jung
    On, Young-Keun
    Huh, Wooseong
    Ko, Jae-Wook
    Kim, Duk-Kyung
    Kim, June Soo
    Lee, Soo-Youn
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2343 - 2345
  • [23] Relationship of polymorphisms in the cytochrome P450 CYP2C9 to warfarin dose requirement
    Aithal, GP
    Day, CP
    Tekes, S
    Cox, J
    Kamali, F
    Kesteven, PJL
    Daly, AK
    HEPATOLOGY, 1997, 26 (04) : 1018 - 1018
  • [24] Genetic polymorphism at exon 4 of cytochrome p450 CYP2C9 in Chinese patients might determine the warfarin dose requirement.
    Leung, AYH
    Chow, HCH
    Kwong, YL
    Lie, AKW
    Fung, ATK
    Chow, WH
    Yip, ASB
    Liang, R
    BLOOD, 2000, 96 (11) : 646A - +
  • [25] Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population
    Ozer, Mahmut
    Demirci, Yeliz
    Hizel, Candan
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Alpan, Serdar
    Genc, Ece
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) : 209 - 214
  • [26] Effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirement in Central China Han populations
    Li, Zhi-Jiang
    Liu, Xu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (11) : 2269 - 2274
  • [27] Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement
    Quinn, Alison L. H.
    Liko, Ina
    Lee, James C.
    PHARMACOGENOMICS, 2017, 18 (11) : 1051 - 1057
  • [28] CYP2C9 gene polymorphisms and warfarin dose requirement: a single-center experience in Turkey
    Yildirim, Rahsan
    Gundogdu, Mehmet
    Kurnaz, Fatih
    Yildirim, Abdulkadir
    Aksoy, Hulya
    Erdem, Fuat
    Kiki, Ilhami
    Akbas, Emin Murat
    Cerrah, Serkan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (06) : 981 - 986
  • [29] Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population
    Chowdhury, Zahid Sadek
    Shahjin, Farah
    Akter, Farhana
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shandaat
    Islam, Reazul
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 341 - 346
  • [30] The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients
    Vannaprasaht, S.
    Sirisawat, P.
    Chiewthanakul, P.
    Tiamkao, S.
    Tiamkao, S.
    Tassaneeyakul, W.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 13 - 14
12345